CLINICAL_TRIALS
trial_result
· 2014-06-03
Clinical Trial Update: PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma [Phase 2]
Summary
Phase 2 trial update of PEG-interferon alfa-2b in patients with stage IV melanoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eastern Cooperative Oncology Group | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED | Results posted: 2014-06-03